BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8292163)

  • 21. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value.
    Edwards JB
    Pathology; 2005 Dec; 37(6):565-8. PubMed ID: 16373240
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparing risks and benefits of colorectal cancer screening in elderly patients.
    Ko CW; Sonnenberg A
    Gastroenterology; 2005 Oct; 129(4):1163-70. PubMed ID: 16230070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colon cancer screening.
    Peltekian KM
    CMAJ; 2006 Mar; 174(7):975; author reply 975-6. PubMed ID: 16567759
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence based medicine (EBM) in practice: applying results of cost-effectiveness analyses.
    Rubenstein JH; Inadomi JM
    Am J Gastroenterol; 2006 Jun; 101(6):1169-71. PubMed ID: 16771930
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnosis of colorectal carcinoma. An update].
    Schneider AR; Caspary WF
    Radiologe; 2003 Feb; 43(2):105-12. PubMed ID: 12624667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer screening and surveillance: the present and the future.
    Rex DK
    Rev Gastroenterol Disord; 2001; 1(1):18-31. PubMed ID: 12120116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
    Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
    J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The detection of colorectal cancer at an asymptomatic stage by screening is useful.
    Komuta K; Furui J; Haraguchi M; Kanematsu T
    Hepatogastroenterology; 2000; 47(34):1011-4. PubMed ID: 11020866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surveillance and cost-effectiveness of colonoscopy in asymptomatic increased risk subjects of colorectal cancer: Ferrara experience].
    Matarese V; Pezzoli A; Trevisani L; Boccia S; Brancaleoni M; Simone L; Feo C; Gullini S
    Recenti Prog Med; 2004; 95(7-8):352-7. PubMed ID: 15303544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for colorectal cancer.
    Saliangas K
    Tech Coloproctol; 2004 Nov; 8 Suppl 1():s10-3. PubMed ID: 15655587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal DNA for colorectal-cancer screening.
    Frossard JL; de Peyer R
    N Engl J Med; 2005 Mar; 352(13):1384-5; author reply 1384-5. PubMed ID: 15800239
    [No Abstract]   [Full Text] [Related]  

  • 33. Screening for colorectal cancer.
    Allison JE
    N Engl J Med; 1993 Oct; 329(18):1352; author reply 1353-4. PubMed ID: 8413420
    [No Abstract]   [Full Text] [Related]  

  • 34. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for colorectal cancer.
    Ahlquist DA; Moertel CG; McGill DB
    N Engl J Med; 1993 Oct; 329(18):1351; author reply 1353-4. PubMed ID: 8292162
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening.
    Heitman SJ; Manns BJ; Hilsden RJ; Fong A; Dean S; Romagnuolo J
    CMAJ; 2005 Oct; 173(8):877-81. PubMed ID: 16217110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Colorectal cancer screening is profitable].
    Pikkarainen P
    Duodecim; 1999; 115(17):1813-4. PubMed ID: 11941648
    [No Abstract]   [Full Text] [Related]  

  • 39. Modelling future capacity needs and spending on colonoscopy in the English bowel cancer screening programme.
    Nnoaham KE; Lines C
    Gut; 2008 Sep; 57(9):1238-45. PubMed ID: 18441004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for colorectal cancer.
    Budenholzer B
    CMAJ; 2001 Apr; 164(7):965-6; author reply 967-8. PubMed ID: 11314442
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.